| Price | 8.60p on 19-11-2025 at 06:00:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 50,000.00 at 8.60p |
| Day's Volume: | 0 |
| Last Close: | 8.60p |
| Open: | 0.00p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 5.00p - 9.00p |
| Market Capitalisation: | £528.16m |
| VWAP: | 0.00p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 50,000 | 8.60p | Uncrossing Trade |
16:35:05 - 18-Nov-25 |
| Buy* | 15,000 | 8.80p | Suspected BUY Trade |
14:00:15 - 18-Nov-25 |
| Unknown* | 125,000 | 8.385p | Ordinary |
13:24:35 - 18-Nov-25 |
| Unknown* | 150,000 | 8.4266p | Ordinary |
13:23:13 - 18-Nov-25 |
| Sell* | 1,039 | 8.50p | SI Trade |
12:27:43 - 18-Nov-25 |
| Unknown* | 155,000 | 8.575p | Ordinary |
12:27:43 - 18-Nov-25 |
| Buy* | 1,061 | 8.95p | Ordinary |
11:27:30 - 18-Nov-25 |
| Sell* | 32,895 | 8.36p | Ordinary |
11:11:51 - 18-Nov-25 |
| Sell* | 39,997 | 8.40p | Uncrossing Trade |
11:00:28 - 18-Nov-25 |
| Buy* | 5,434 | 8.98p | Ordinary |
10:11:57 - 18-Nov-25 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |
| 16th Oct 2025 7:00 am | RNS | Further progress in Phase I/IIa PROTECT trial |
| 31st Jul 2025 7:00 am | RNS-R | Grass MATA MPL Publications in Allergy Journal |
| 21st Jul 2025 7:00 am | RNS | Trading update for the year ended 30 June 2025 |
| 11th Jul 2025 7:00 am | RNS | PDMR Dealings |
| 13th Jun 2025 7:00 am | RNS-R | Allergy Therapeutics presents findings at EAACI |
| 10th Jun 2025 7:04 am | RNS-R | EAACI Early Career Research Award |
| 31st Mar 2025 7:00 am | RNS | Interim Results for six months ended 31 Dec 2024 |
